A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/30 (2006.01) A61K 31/132 (2006.01) A61P 3/10 (2006.01) A61P 9/00 (2006.01)
Patent
CA 2496411
This invention is directed in part to novel doses, dosage formulations, and routes of administration of such doses and dose formulations, said dose and dose formulations containing one or more copper chelators, for example, one or more trientine active agents, including trientine analogues, trientine salts, trientine prodrugs, and trientine derivatives, useful in the treatment of diseases, disorders and conditions, including in indications where copper may play a role.
Cette invention concerne, en partie, de nouvelles doses et formes posologiques, et des modes d'administration desdites doses et formes posologiques contenant un ou plusieurs chélateurs du cuivre, par exemple une ou plusieurs substances actives de trientine, y compris des analogues de trientine, des sels de trientine, des promédicaments de trientine, et des dérivés de trientine, utiles dans le traitement de maladies, troubles ou pathologies, notamment dans des indications où le cuivre peut jouer un rôle.
Baker John Richard
Beeley Nigel Robert Arnold
Cooper Garth James Smith
Philera New Zealand Limited
Protemix Corporation Limited
Riches Mckenzie & Herbert Llp
LandOfFree
Dosage forms and related therapies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dosage forms and related therapies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage forms and related therapies will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1402406